hydrazine has been researched along with Cochlear Hearing Loss in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arif, AR; Chen, W; Luo, S; Wang, Y; Xue, M; Zhao, M | 1 |
| De Carne, C; Elefant, E; Favier, R; Gkalea, V; Lapusneanu, R; Rigouzzo, A | 1 |
| Alarcón, P; Conte, G; López, M | 1 |
3 other study(ies) available for hydrazine and Cochlear Hearing Loss
| Article | Year |
|---|---|
Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
Topics: Benzoates; Hearing Loss, Sensorineural; Humans; Hydrazines; Male; Molecular Motor Proteins; Mutation; Myosin Heavy Chains; Pyrazoles; Thiazoles; Thiophenes; Thrombocytopenia; Treatment Failure | 2022 |
Eltrombopag to Treat Thrombocytopenia During Last Month of Pregnancy in a Woman With MYH9-Related Disease: A Case Report.
Topics: Adult; Benzoates; Female; Hearing Loss, Sensorineural; Humans; Hydrazines; Pregnancy; Pregnancy Complications, Hematologic; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia | 2018 |
[Hereditary thrombocytopenia associated with a mutation in the MYH-9 gene. Report of one case].
Topics: Benzoates; Biopsy; Female; Genetic Diseases, Inborn; Hearing Loss, Sensorineural; Humans; Hydrazines; Middle Aged; Mutation; Platelet Count; Pyrazoles; Thrombocytopenia | 2018 |